Paravita (RUBIMED AG)


Welcome to the PulseAid listing for the Paravita drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RUBIMED AG
NON-PROPRIETARY NAME: Formica rufa, Sus Scrofa Cerebellum, Acetylcholine, and Scabies Lesion Lysate (Human)
SUBSTANCE NAME: FORMICA RUFA; SUS SCROFA CEREBELLUM; ACETYLCHOLINE; SCABIES LESION LYSATE (HUMAN)
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


Paravita HUMAN OTC DRUG Details:

Item DescriptionParavita from RUBIMED AG
LABELER NAME: RUBIMED AG
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 21; 30; 200([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66343-004_fbd55255-19c8-4811-a7c3-3ecdf217e948
PRODUCT NDC: 66343-004
APPLICATION NUMBER:

Other FORMICA RUFA; SUS SCROFA CEREBELLUM; ACETYLCHOLINE; SCABIES LESION LYSATE (HUMAN) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RUBIMED AGParavita